NCT04575428View on ClinicalTrials.gov

Splanchnic Nerve Block for Therapy of Chronic Heart Failure (Splanchnic III)

PHASE2CompletedINTERVENTIONAL

Enrollment

5

Participants

Timeline

Start Date

February 5, 2020

Primary Completion Date

June 16, 2021

Study Completion Date

June 16, 2021

Conditions

Chronic Heart Failure

Interventions

DRUG

Splanchnic nerve block

Percutaneous splanchnic nerve block

Trial Locations (1)

27710

Duke University Medical Center, Durham

Sponsors

Lead Sponsor

Duke University

All Listed Sponsors

lead

Duke University

OTHER